Home > Insider Trading > Filing (0001209191-15-032438)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520697	Acadia Healthcare Company Inc.	ACHC	Services-Specialty Outpatient Facilities, Nec (8093)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1243878	A Joey Jacobs	Acadia Healthcare Company, Inc. 830 Crescent Centre Drive, Suite 610 Franklin TN 37067	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-04-01	9,023	$69.89	325,020	No	4	S	Direct
Common Stock	Acquisiton	2015-04-02	8,831	$50.75	333,851	No	4	M	Direct
Common Stock	Acquisiton	2015-04-02	18,313	$15.96	352,164	No	4	M	Direct
Common Stock	Acquisiton	2015-04-02	16,650	$29.39	368,814	No	4	M	Direct
Common Stock	Disposition	2015-04-02	28,540	$70.20	340,274	No	4	F	Direct
Common Stock	Disposition	2015-04-02	15,254	$70.16	325,020	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2015-04-02	8,831	$0.00	8,831	$50.75
Common Stock	Stock Option	Disposition	2015-04-02	18,313	$0.00	18,313	$15.96
Common Stock	Stock Option	Disposition	2015-04-02	16,650	$0.00	16,650	$29.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,494	2015-02-27	2024-02-27	No	4	M	Direct
18,315	2014-03-19	2022-03-19	No	4	M	Direct
33,300	2014-03-29	2023-03-29	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	617,649	Indirect	See Footnote

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.1800 to $70.9600, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.7400 to $71.0000, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Mr. Jacobs expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
By the Jeremy Brent Jacobs GST Non-Exempt Trust u/a/d 04/26/2011 and Scott Douglas Jacobs GST Non-Exempt Trust u/a/d 04/26/2011.